1,168
Participants
Start Date
September 9, 2011
Primary Completion Date
May 12, 2015
Study Completion Date
May 12, 2015
botulinum toxin Type A
155-195 U of botulinum toxin Type A administered intramuscularly in the face, head, and neck areas as directed by physician (approximately every 12 weeks) for 1 year.
Munich
Oviedo
Stockholm
London
Lead Sponsor
Allergan
INDUSTRY